Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Assembly Biosciences Inc (NASDAQ:ASMB)

25.99
Delayed Data
As of 3:59pm ET
 +0.21 / +0.81%
Today’s Change
4.60
Today|||52-Week Range
28.18
+113.91%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$445.1M

Company Description

Assembly Biosciences, Inc. is a biotechnology company, which engages in the development of two innovative platform programs: hepatitis b virus and microbiome program. It focuses on advancing science and enhancing the health and well-being of patients with hard-to-treat infectious diseases. The company was founded on October 7, 2005 and is headquartered in New York, NY.

Contact Information

Assembly Biosciences, Inc.
11711 North Meridiyan Street
Carmel Indiana 46032
P:(646) 746-8002
Investor Relations:

Employees

Shareholders

Other institutional53.61%
Individual stakeholders17.12%
Mutual fund holders14.15%

Top Executives

Derek A. SmallPresident, Chief Executive Officer & Director
David J. BarrettChief Operating & Financial Officer
Uri A. LopatinChief Medical Officer & Vice President
Richard J. ColonnoChief Scientific Officer
Hong Mei HuangVP-Information Technology & Informatics